AI assistant
Sending…
Trevi Therapeutics, Inc. — Director's Dealing 2021
Feb 3, 2021
32321_dirs_2021-02-03_df83270c-231e-4889-8bb8-7e4f8176ee4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Trevi Therapeutics, Inc. (TRVI)
CIK: 0001563880
Period of Report: 2021-02-01
Reporting Person: Forbes William P (Chief Development Officer)
More from Trevi Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Apr 21
Annual Report
2026
Apr 21
Capital/Financing Update
2026
Apr 17
Capital/Financing Update
2026
Apr 16
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20